BiomX Inc. (PHGE): Nasdaq/NYSE listing notice — BiomX receives NYSE American delisting notice for stockholders' equity deficiency; discloses going concern

BiomX Inc.

Notified for failing to meet minimum stockholders' equity requirements under Sections 1003(a)(i)-(iii) (thresholds $2M-$6M).
Must submit compliance plan by April 24, 2026; must regain compliance by September 25, 2027.
Audit opinion for FY2025 includes a going concern qualification.
Common stock (PHGE) continues trading on NYSE American; delisting proceedings possible if plan is not accepted.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

BiomX Inc. received a nyse_american deficiency notice notice regarding stockholders equity (rules 1003(a)(i), 1003(a)(ii), 1003(a)(iii)).

Exchange: nyse american
Notice: deficiency notice
Deficiency: stockholders equity
Rules: 1003(a)(i), 1003(a)(ii), 1003(a)(iii)

Exact text from the filing

March 25, 2026, BiomX, Inc, a Delaware corporation (the “Company”), received a written notice (the “Notice”) from the NYSE American LLC (the “NYSE American”) indicating that the Company is not in compliance with the NYSE American continued listing standards set forth in Section 1003(a)(i) of the NYSE American Company Guide (the “Company Guide”) requiring a company to have stockholders’ equity of at least $2.0 million if it has reported losses from continuing operations and/or net losses in two of its three most recent fiscal years, Section 1003(a)(ii) of the Company Guide requiring a company t

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

BiomX Inc. filing history →

Source: SEC EDGAR

accession 0001213900-26-035605

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.